Phoenix Biotech Aquisition Stock Quote PBAX - Stock Price, News, Charts, Message Board, Trades

Unlock more advanced trading tools

Join ADVFN today

Current Price

5.85

Bid

5.00

Ask

5.85

Volume

0.00 Day's Range 0.00

4.12 52 Week Range 12.80

Market Cap

36.539M

Previous Close

5.85

Open

Last Trade

Last Trade Time

Financial Volume

VWAP

Average Volume (3m)

36,343

Shares Outstanding

6,246,000

Dividend Yield

PE Ratio

-14.41

Earnings Per Share (EPS)

-0.41

Revenue

Net Profit

-2.54M

Phoenix Biotech Acquisition Corp is a blank check company. It is formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The company intends to pursue an acquisition opportuni... Phoenix Biotech Acquisition Corp is a blank check company. It is formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The company intends to pursue an acquisition opportunity in any business, industry, sector or geographical location, industries that complement management team's background, and to capitalize on the ability of management team to identify and acquire a business in the healthcare or healthcare related industries in the United States and Europe. Show more

Sector

Blank Checks

Industry

Blank Checks

Website

www.cero.bio/

Headquarters

Wilmington, Delaware, USA

Founded

1970

Phoenix Biotech Aquisition Corporation is listed in the Blank Checks sector of the NASDAQ with ticker PBAX. The last closing price for Phoenix Biotech Aquisition was $5.85. Over the last year, Phoenix Biotech Aquisition shares have traded in a share price range of $ 4.12 to $ 12.80.

Phoenix Biotech Aquisition currently has 6,246,000 shares outstanding. The market capitalization of Phoenix Biotech Aquisition is $36.54 million. Phoenix Biotech Aquisition has a price to earnings ratio (PE ratio) of -14.41.

Phoenix Biotech Acquisition Corp. and CERo Therapeutics, Inc. Announce Close of Business Combination

Phoenix Biotech Acquisition Corp. (NASDAQ:PBAX) (“PBAX”) and CERo Therapeutics, Inc., an innovative immunotherapy company seeking to advance the next generation of engineered T cell therapeutics...

CERo Therapeutics, Inc. and Phoenix Biotech Acquisition Corp. Announce Merger Agreement to Create Public Company Advancing the Development of Next Generation Engineered T Cell Therapeutics

CERo is an innovative immunotherapy company seeking to advance the next generation of engineered T cell therapeutics that employ phagocytic mechanisms. Its lead product candidate is expected to...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	-5.37	-47.8609625668	11.22	12.8	4.12	36343	7.00553898	CS
26	-5.02	-46.1821527139	10.87	12.8	4.12	6992	8.53717028	CS
52	-4.97	-45.9334565619	10.82	12.8	4.12	5752	9.66485245	CS
156	-4.29	-42.3076923077	10.14	12.8	4.12	29444	10.03063393	CS
260	-4.29	-42.3076923077	10.14	12.8	4.12	29444	10.03063393	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
CSLRComplete Solaria Inc	$ 0.7303 (91.73%)	25.8M
MULNMullen Automotive Inc	$ 5.73 (81.33%)	72.12M
DCPHDeciphera Pharmaceuticals Inc	$ 25.28 (72.56%)	50.72M
CAUDCollective Audience Inc	$ 0.6377 (63.51%)	157.73M
LICNLichen China Limited	$ 2.03 (48.18%)	3.96M
CLVRClever Leaves Holdings Inc	$ 1.62 (-60.58%)	768.37k
ADXNAddex Therapeutics Ltd	$ 7.68 (-52.30%)	160.84k
TSDDGraniteShares ETF Trust GraniteShares	$ 17.1879 (-30.97%)	1.64M
TSLZT Rex 2X Inverse Tesla Daily Target ETF	$ 27.23 (-30.66%)	7.72M
MFImF International Ltd	$ 1.665 (-28.54%)	3.55M
TSLATesla Inc	$ 194.05 (15.31%)	243.77M
SINTSiNtx Technologies Inc	$ 0.053477 (32.37%)	174.36M
CAUDCollective Audience Inc	$ 0.6377 (63.51%)	157.73M
SOFISoFi Technologies Inc	$ 7.045 (-10.48%)	149.63M
SQQQProShares UltraPro Short QQQ	$ 11.31 (-1.05%)	97.67M